Stockscreener 앱 받기
0.50%
전일 마감가:
$193.78
열려 있는:
$194.58
하루 거래량:
4.23M
Relative Volume:
1.03
시가총액:
$137.82B
수익:
$24.57B
순이익/손실:
$3.60B
주가수익비율:
38.56
EPS:
5.051
순현금흐름:
$5.26B
1주 성능:
+2.71%
1개월 성능:
-0.24%
6개월 성능:
-6.84%
1년 성능:
+4.24%
1일 변동 폭
$194.26
$197.02
1주일 범위
$188.06
$200.40
52주 변동 폭
$180.03
$242.80
다나허 Stock (DHR) Company Profile
명칭
Danaher Corp
전화
(202) 828-0850
주소
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
194.75 | 137.82B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
526.60 | 195.70B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
589.25 | 46.80B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
121.87 | 34.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
327.77 | 32.18B | 3.17B | 642.63M | 516.49M | 10.77 |
다나허 Stock (DHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 다운그레이드 | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-03-14 | 업그레이드 | Stifel | Hold → Buy |
| 2025-02-03 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-31 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-12-18 | 개시 | HSBC Securities | Hold |
| 2023-12-13 | 재개 | Wolfe Research | Peer Perform |
| 2023-12-07 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-01 | 개시 | SVB Securities | Outperform |
| 2023-04-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-10-24 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-08-17 | 재개 | Bernstein | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-06-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | 개시 | Bernstein | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-10 | 재확인 | BofA Securities | Buy |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 재확인 | Goldman | Buy |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-04-07 | 재개 | Robert W. Baird | Outperform |
| 2021-03-03 | 재개 | Barclays | Overweight |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 재개 | Stifel | Hold |
| 2019-10-28 | 재확인 | Needham | Buy |
| 2019-10-14 | 재개 | Credit Suisse | Outperform |
| 2019-07-19 | 재확인 | Needham | Buy |
| 2019-06-11 | 개시 | Piper Jaffray | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-04-17 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2019-02-25 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-04-20 | 재확인 | Stifel | Buy |
모두보기
다나허 주식(DHR)의 최신 뉴스
Wealth Enhancement Trust Services Inc. Buys Shares of 14,087 Danaher Corporation $DHR - MarketBeat
Ninety One UK Ltd Sells 12,023 Shares of Danaher Corporation $DHR - MarketBeat
Cwm LLC Purchases 9,542 Shares of Danaher Corporation $DHR - MarketBeat
Barclays and Evercore Stay Positive on Danaher (DHR) Despite Cutting Price Targets - Yahoo Finance
Best Biotech Stocks To ConsiderApril 18th - MarketBeat
How Danaher’s Expanded Infectious Disease Partnership Could Shape DHR’s Recurring Revenue Story - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Grows Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Danaher Corporation (DHR) Secures $5 Billion Revolving Credit Fa - GuruFocus
Saratoga Large Capitalization Value Portfolio's Danaher Corp(DHR) Holding History - GuruFocus
Top Biotech Stocks To Watch NowApril 17th - MarketBeat
Danaher Corporation $DHR Stake Lifted by Whittier Trust Co. - MarketBeat
DHR Maintained by Baird -- Price Target Lowered to $249 - GuruFocus
Danaher (NYSE: DHR) secures $5B 364-day revolving credit facility - Stock Titan
KBC Group NV Has $65.13 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Lbp Am Sa Purchases 46,347 Shares of Danaher Corporation $DHR - MarketBeat
Fisher Funds Management LTD Has $91.23 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher Corporation (NYSE:DHR) Short Interest Up 25.0% in March - MarketBeat
Top Biotech Stocks To Watch TodayApril 16th - MarketBeat
Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock? - Yahoo Finance
Chart of the Week: Danaher Stock Flashes Bullish Signals - Barron's
Ahead of Danaher (DHR) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Greenwood Capital Associates LLC Has $5.01 Million Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Border to Coast Pensions Partnership Ltd - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
SeaBridge Investment Advisors LLC Takes Position in Danaher Corporation $DHR - MarketBeat
What to expect from Danaher Corporation's Q1 2026 earnings report - MSN
Danaher Corporation $DHR Shares Sold by Foster Victor Wealth Advisors LLC - MarketBeat
Danaher Corp. stock (US2358511028): Why does its business model matter more now for long-term invest - AD HOC NEWS
15,141 Shares in Danaher Corporation $DHR Purchased by Annex Advisory Services LLC - MarketBeat
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration - PR Newswire
Danaher Corp. stock (US2358511028): Is its life sciences moat strong enough to unlock new upside? - AD HOC NEWS
DHR Maintained by Barclays -- Price Target Lowered to $230 - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
TD Cowen Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price - MarketBeat
Norris Perne & French LLP MI Boosts Stake in Danaher Corporation $DHR - MarketBeat
JM2 Capital Inc. Takes $1.33 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Projected to Post Earnings on Tuesday - MarketBeat
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DHR Maintained by Goldman Sachs -- Price Target Lowered to $230 - GuruFocus
The Goldman Sachs Group Lowers Danaher (NYSE:DHR) Price Target to $230.00 - MarketBeat
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing? - Yahoo Finance
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Unit Receives CE Mark for Rapid Infection Test - marketscreener.com
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes - PR Newswire
Best Biotech Stocks To Keep An Eye OnApril 12th - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stake in Danaher Corporation $DHR - MarketBeat
다나허 (DHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다나허 주식 (DHR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Milosevich Gregory M | Executive Vice President |
Feb 19 '26 |
Sale |
208.01 |
1,320 |
274,575 |
5,099 |
2.05%
자본화:
|
볼륨(24시간):